Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Liver Cancer

In brief

This study is a further observation and follow-up of the patients enrolled in the registration number NCT06341270 to further evaluate the efficacy of TEAS on postoperative chronic pain, quality of life and survival rate in patients undergoing hepatectomy.

Key facts

Study ID

NCT06406244

Run by

West China Hospital

People needed

524

Starts

2024-04-20

Expected to finish

2026-10-20

Last updated by the study team

2024-05-09

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 18-80 years old; ASA physical status classⅠ-Ⅲ; Patients scheduled for elective hepatectomy.

You may not qualify if…

• Have a history of epilepsy; Rash or local infection over the acupoint stimulation skin area; Pregnancy or breastfeeding; Mental retardation, psychiatric, or neurological disease; Inability to comprehend the numeric rating scale (NRS); Implantation of a cardiac pacemaker, cardioverter, or defibrillator; Chronic opioid use; Metastases in other organs.

Where it is running

• West China Hospital — Chengdu, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.